14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Clovis Oncology prices

Date Open High Low Close Volume
Jun 13, 2016 $14.00 $14.40 $13.55 $13.57 711 186
Jun 10, 2016 $14.90 $15.10 $14.05 $14.11 1 053 772
Jun 09, 2016 $15.74 $15.89 $15.01 $15.23 631 970
Jun 08, 2016 $16.32 $16.43 $15.67 $15.87 826 235
Jun 07, 2016 $17.19 $17.33 $16.37 $16.39 1 029 250
Jun 06, 2016 $16.42 $17.38 $16.11 $17.34 968 963
Jun 03, 2016 $17.30 $17.48 $16.26 $16.30 1 396 236
Jun 02, 2016 $17.05 $17.44 $16.93 $17.27 902 149
Jun 01, 2016 $16.93 $17.22 $16.68 $17.05 947 130
May 31, 2016 $16.80 $17.21 $16.32 $16.83 678 478
May 27, 2016 $16.45 $16.75 $15.72 $16.70 956 458
May 26, 2016 $16.00 $16.80 $15.97 $16.44 1 283 054
May 25, 2016 $15.65 $16.11 $15.51 $16.00 1 434 846
May 24, 2016 $15.11 $15.85 $14.81 $15.58 1 387 234
May 23, 2016 $14.35 $15.30 $14.32 $14.91 1 134 454
May 20, 2016 $13.76 $14.65 $13.67 $14.50 930 902
May 19, 2016 $13.74 $14.10 $13.19 $13.65 1 052 087
May 18, 2016 $12.77 $13.80 $12.73 $13.75 765 026
May 17, 2016 $12.97 $13.21 $12.66 $12.78 658 849
May 16, 2016 $12.66 $13.34 $12.21 $13.09 1 050 052
May 13, 2016 $12.09 $12.73 $12.01 $12.50 669 834
May 12, 2016 $12.51 $12.57 $11.58 $12.17 933 823
May 11, 2016 $13.01 $13.06 $12.33 $12.39 544 376
May 10, 2016 $13.85 $13.88 $13.02 $13.09 691 759
May 09, 2016 $13.15 $13.85 $13.15 $13.74 757 966
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT